Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Societe Generale Asset Management
Paris, France
- Ownership
- Private
- Development stage
- Other
01
Overview
Societe Generale Asset Management (SGAM) was the investment management subsidiary of the French financial services group Société Générale. The firm provided a wide range of investment solutions, including equity, fixed income, and alternative investments, to institutional and individual clients globally. In 2010, SGAM merged with Crédit Agricole Asset Management to form Amundi, which became one of the largest asset managers in Europe. While SGAM managed various sector-specific funds, including those focused on healthcare and biotechnology, it was a financial institution rather than a life sciences company.
- Industry
- Investors
Beyond the preview
Go deeper on Societe Generale Asset Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Societe Generale Asset Management.